Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hip implant stability under the microscope: 2-Year tracking study begins

NCT ID NCT05818878

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 26 adults under 70 getting a hip replacement to see how stable a new type of hip implant stays over 2 years. Using special X-rays, doctors measure tiny movements of the implant right after surgery and at 6 months, 1 year, and 2 years. The goal is to learn if the implant stays firmly in place, not to treat or cure a disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 26 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2020

Expected to finish

Nov 2025

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

26 patients who entirely fulfil the inclusion/exclusion criteria. The patients will be recruited in a period of 12 months.

Ages

Up to 70 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primary osteoarthritis of the hip necessitating primary hip replacement, * Suitability for straight cementless stem, * Adult male and female under 70years old, * Ability to give informed consent, * Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up. Exclusion Criteria: * Post-traumatic deformity in the affected hip, * Patient suffering by rheumatoid arthritis, * Patient suffering by congenital or developmental deformity, * Severe osteoporosis, * Earlier surgery in the hip to be operated on, * Perioperative fracture, * Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain, * Patients with a history of active infection * Pregnant women or those seeking to become pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary osteoarthritis of the hip are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Southerland Public Hospital

    Sydney, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.